search
Back to results

Heart & Health Study

Primary Purpose

Heart Disease

Status
Completed
Phase
Not Applicable
Locations
United States
Study Type
Interventional
Intervention
Fish Oil
Placebo
Sponsored by
USDA, Western Human Nutrition Research Center
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional prevention trial for Heart Disease focused on measuring ALOX5, 5-lipoxygenase, Heart Disease, Blacks

Eligibility Criteria

20 Years - 59 Years (Adult)All SexesAccepts Healthy Volunteers

Inclusion Criteria:

  • African-American, Black, or persons of African Descent
  • Generally Healthy
  • 20 - 59 years of age

Exclusion Criteria:

  • Chronic Diseases (Heart disease, cancer, diabetes, etc.)
  • Smoke > 14 cigarettes per week
  • Consume > 14 alcoholic drinks per week
  • Pregnant Women

Sites / Locations

  • UC Davis, Western Human Nutrition Research Center
  • Ethnich Health Institute
  • UC Davis (TICON-1)

Arms of the Study

Arm 1

Arm 2

Arm Type

Experimental

Placebo Comparator

Arm Label

1

2

Arm Description

Outcomes

Primary Outcome Measures

(a) ALOX5 mRNA and protein in resting and stimulated cultures of purified monocytes and purified granulocytes (b) Arachidonic acid-derived leukotrienes in resting and stimulated cultures of whole blood, purified monocytes and purified granulocytes

Secondary Outcome Measures

Proinflammatory cytokines, C-reactive protein, triglycerides, glucose and insulin in plasma, and resting heart rate and blood pressure

Full Information

First Posted
September 5, 2007
Last Updated
August 3, 2011
Sponsor
USDA, Western Human Nutrition Research Center
Collaborators
National Center for Complementary and Integrative Health (NCCIH), Office of Dietary Supplements (ODS), University of California, Davis, United States Department of Agriculture (USDA), Alta Bates Summit Medical Center, University of Southern California
search

1. Study Identification

Unique Protocol Identification Number
NCT00536185
Brief Title
Heart & Health Study
Official Title
Variation in the ALOX5 Gene and Response to Omega-3 Fatty Acid Supplements
Study Type
Interventional

2. Study Status

Record Verification Date
August 2011
Overall Recruitment Status
Completed
Study Start Date
December 2006 (undefined)
Primary Completion Date
July 2008 (Actual)
Study Completion Date
July 2008 (Actual)

3. Sponsor/Collaborators

Name of the Sponsor
USDA, Western Human Nutrition Research Center
Collaborators
National Center for Complementary and Integrative Health (NCCIH), Office of Dietary Supplements (ODS), University of California, Davis, United States Department of Agriculture (USDA), Alta Bates Summit Medical Center, University of Southern California

4. Oversight

Data Monitoring Committee
No

5. Study Description

Brief Summary
We hope to learn more about why certain people have higher levels of the 5-LO protein and whether taking fish oil supplements gives such individuals greater protection than others against cardiovascular disease. The 5-LO protein is important in the development of heart disease because it converts a type of oil from meat into a compound that can cause inflammation in blood vessels. This inflammation is a major cause of heart disease. Researchers think that people with higher levels of a protein called 5-LO in their white blood cells may have a healthier response to using fish oil supplements than do people with lower levels of this protein.
Detailed Description
Fish oil supplements will be given to subjects with different variants in the promoter region of the arachidonate 5-lipoxygenase (ALOX5) gene and outcome measures will be evaluated after 6 wk of supplementation. These outcomes include ALOX5 protein levels (also called 5-lipoxygenase, or 5-LO), leukotriene levels, markers of inflammation, and blood lipids. The 5-LO enzyme converts arachidonic acid (AA) to leukotrienes that promote inflammation. Subjects with different promoter variants are hypothesized to have different basal or stimulated levels of 5-LO expression. Preliminary data suggests that subjects with a promoter variant that causes increased 5-LO expression also may have a "better" anti-inflammatory or lipid-lowering response to fish oil supplements. The homozygous variant genotype is much more common in African Americans than other groups thus we propose to conduct the study in African Americans. The fish oil eicosapentaenoic acid (EPA) competitively inhibits conversion of AA to pro-inflammatory 4-series leukotrienes. The grant proposes to conduct a community-based, double-masked, randomized, placebo-controlled trial; n = 15/group, total = 166 (genotypes 44 will have n = 8). The intervention group will receive 5.0 g/d fish oil concentrate (3.0 g/d EPA + DHA) for 6 wk. The study will be conducted in Oakland, Davis, and Sacramento, California where African Americans 20 - 59 y of age without serious chronic disease will be recruited. A recent observational study indicates that subjects with a variant allele for ALOX5 may be at greater risk for cardiovascular disease and, at the same time, may derive a greater benefit from omega-3 fatty acid supplements than do subjects homozygous for the common allele. The variant alleles are less common in the white population (18%) than in the black population (52%). Since African Americans have a higher prevalence of cardiovascular disease and of the ALOX5 variant alleles, as shown in epidemiologic studies, they may have a greater benefit from omega-3 supplementation in the reduction of inflammation and cardiovascular risk factors. Recruitment will be conducted through the community service, Ethnic Health Institute (EHI), of Alta Bates Summit Medical Center in conjunction with UCD, and outreach efforts from the USDA, ARS, Western Human Nutrition Research Center (WHNRC) at UC Davis. We will determine if subjects with one or two variant ALOX5 alleles have higher ALOX5 gene expression, higher production of AA-derived leukotrienes, and a better response to omega-3 supplements than do subjects homozygous for the common allele.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Heart Disease
Keywords
ALOX5, 5-lipoxygenase, Heart Disease, Blacks

7. Study Design

Primary Purpose
Prevention
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
ParticipantInvestigatorOutcomes Assessor
Allocation
Randomized
Enrollment
166 (Anticipated)

8. Arms, Groups, and Interventions

Arm Title
1
Arm Type
Experimental
Arm Title
2
Arm Type
Placebo Comparator
Intervention Type
Dietary Supplement
Intervention Name(s)
Fish Oil
Intervention Description
capsules, 5.0 g/d fish oil concentrate (3.0 g/d EPA + DHA), 6 weeks
Intervention Type
Dietary Supplement
Intervention Name(s)
Placebo
Intervention Description
capsule, 5.0 g/d corn/soybean oil (50/50 mixture), 6 weeks
Primary Outcome Measure Information:
Title
(a) ALOX5 mRNA and protein in resting and stimulated cultures of purified monocytes and purified granulocytes (b) Arachidonic acid-derived leukotrienes in resting and stimulated cultures of whole blood, purified monocytes and purified granulocytes
Time Frame
6 weeks
Secondary Outcome Measure Information:
Title
Proinflammatory cytokines, C-reactive protein, triglycerides, glucose and insulin in plasma, and resting heart rate and blood pressure
Time Frame
6 weeks

10. Eligibility

Sex
All
Minimum Age & Unit of Time
20 Years
Maximum Age & Unit of Time
59 Years
Accepts Healthy Volunteers
Accepts Healthy Volunteers
Eligibility Criteria
Inclusion Criteria: African-American, Black, or persons of African Descent Generally Healthy 20 - 59 years of age Exclusion Criteria: Chronic Diseases (Heart disease, cancer, diabetes, etc.) Smoke > 14 cigarettes per week Consume > 14 alcoholic drinks per week Pregnant Women
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Charles B Stephensen, PhD
Organizational Affiliation
UC Davis & U.S. Department of Agriculture
Official's Role
Principal Investigator
Facility Information:
Facility Name
UC Davis, Western Human Nutrition Research Center
City
Davis
State/Province
California
ZIP/Postal Code
95616
Country
United States
Facility Name
Ethnich Health Institute
City
Oakland
State/Province
California
ZIP/Postal Code
94609
Country
United States
Facility Name
UC Davis (TICON-1)
City
Sacramento
State/Province
California
ZIP/Postal Code
95820
Country
United States

12. IPD Sharing Statement

Citations:
PubMed Identifier
24259553
Citation
O'Sullivan A, Armstrong P, Schuster GU, Pedersen TL, Allayee H, Stephensen CB, Newman JW. Habitual diets rich in dark-green vegetables are associated with an increased response to omega-3 fatty acid supplementation in Americans of African ancestry. J Nutr. 2014 Feb;144(2):123-31. doi: 10.3945/jn.113.181875. Epub 2013 Nov 20.
Results Reference
derived
PubMed Identifier
22739369
Citation
Armstrong P, Kelley DS, Newman JW, Staggers FE Sr, Hartiala J, Allayee H, Stephensen CB. Arachidonate 5-lipoxygenase gene variants affect response to fish oil supplementation by healthy African Americans. J Nutr. 2012 Aug;142(8):1417-28. doi: 10.3945/jn.112.159814. Epub 2012 Jun 27.
Results Reference
derived
PubMed Identifier
19717473
Citation
Vikman S, Brena RM, Armstrong P, Hartiala J, Stephensen CB, Allayee H. Functional analysis of 5-lipoxygenase promoter repeat variants. Hum Mol Genet. 2009 Dec 1;18(23):4521-9. doi: 10.1093/hmg/ddp414. Epub 2009 Aug 28.
Results Reference
derived
Links:
URL
http://www.ars.usda.gov/main/site_main.htm?modecode=53062500
Description
Western Human Nutrition Research website

Learn more about this trial

Heart & Health Study

We'll reach out to this number within 24 hrs